Immunovant
IMVT
IMVT
197 hedge funds and large institutions have $1.97B invested in Immunovant in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 82 increasing their positions, 65 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
6% less funds holding
Funds holding: 209 → 197 (-12)
13% less capital invested
Capital invested by funds: $2.27B → $1.97B (-$300M)
29% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 35
Holders
197
Holding in Top 10
5
Calls
$24.3M
Puts
$23.6M
Top Buyers
| 1 | +$74.7M | |
| 2 | +$63.1M | |
| 3 | +$42.9M | |
| 4 |
AC
Armistice Capital
New York
|
+$32.5M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$14.9M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$31.7M | |
| 3 | -$27.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$24.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$20.4M |